Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.

Yoshi MiyamotoChihiro KawasoeKaoru ItoNobuyuki OguriTakaya MurashimaToyoharu KamibeppuTakahiro NagaiHiroki TakamoriToshio KamimuraShoichiro MukaiYuichiro SatoToshiyuki Kamoto

Published in: Journal of medical case reports (2023)

Methotrexate-associated lymphoproliferative disorders should be considered in the event of newly appearing neoplastic lesions, even during follow-up for renal cell carcinoma, if methotrexate is being administered.

Keyphrases

renal cell carcinoma
high dose
epstein barr virus
patients undergoing
low dose